Habitual salt preference worsens blood pressure in hospitalized hypertensive patients with omicron infection under epidemic-related stress.

Blood pressure Habitual salt preference Omicron Psychosocial stress

Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
09 Jan 2024
Historique:
received: 04 07 2023
accepted: 31 12 2023
medline: 10 1 2024
pubmed: 10 1 2024
entrez: 9 1 2024
Statut: epublish

Résumé

We investigated the synergistic effect of stress and habitual salt preference (SP) on blood pressure (BP) in the hospitalized Omicron-infected patients. From 15,185 hospitalized Omicron-infected patients who reported having high BP or hypertension, we recruited 662 patients. All patients completed an electronic questionnaire on diet and stress, and were required to complete morning BP monitoring at least three times. The hypertensive group (n = 309) had higher habitual SP (P = 0.015) and COVID-19 related stress (P < 0.001), and had longer hospital stays (7.4 ± 1.5 days vs. 7.2 ± 0.5 days, P = 0.019) compared with controls (n = 353). After adjusting for a wide range of covariates including Omicron epidemic-related stress, habitual SP was found to increase both systolic (4.9 [95% confidence interval (CI), 2.3-7.4] mmHg, P < 0.001) and diastolic (2.1 [95%CI, 0.6-3.6] mmHg, P = 0.006) BP in hypertensive patients, and increase diastolic BP (2.0 [95%CI, 0.2-3.7] mmHg, P = 0.026) in the control group. 31 (8.8%) patients without a history of hypertension were discovered to have elevated BP during hospitalization, and stress was shown to be different in those patients (P < 0.001). In contrast, habitual SP was more common in hypertensive patients with uncontrolled BP, compared with patients with controlled BP (P = 0.002). Habitual SP and psychosocial stress were associated with higher BP in Omicron-infected patients both with and without hypertension. Nonpharmaceutical intervention including dietary guidance and psychiatric therapy are crucial for BP control during the long COVID-19 period.

Sections du résumé

BACKGROUND BACKGROUND
We investigated the synergistic effect of stress and habitual salt preference (SP) on blood pressure (BP) in the hospitalized Omicron-infected patients.
METHODS METHODS
From 15,185 hospitalized Omicron-infected patients who reported having high BP or hypertension, we recruited 662 patients. All patients completed an electronic questionnaire on diet and stress, and were required to complete morning BP monitoring at least three times.
RESULTS RESULTS
The hypertensive group (n = 309) had higher habitual SP (P = 0.015) and COVID-19 related stress (P < 0.001), and had longer hospital stays (7.4 ± 1.5 days vs. 7.2 ± 0.5 days, P = 0.019) compared with controls (n = 353). After adjusting for a wide range of covariates including Omicron epidemic-related stress, habitual SP was found to increase both systolic (4.9 [95% confidence interval (CI), 2.3-7.4] mmHg, P < 0.001) and diastolic (2.1 [95%CI, 0.6-3.6] mmHg, P = 0.006) BP in hypertensive patients, and increase diastolic BP (2.0 [95%CI, 0.2-3.7] mmHg, P = 0.026) in the control group. 31 (8.8%) patients without a history of hypertension were discovered to have elevated BP during hospitalization, and stress was shown to be different in those patients (P < 0.001). In contrast, habitual SP was more common in hypertensive patients with uncontrolled BP, compared with patients with controlled BP (P = 0.002).
CONCLUSIONS CONCLUSIONS
Habitual SP and psychosocial stress were associated with higher BP in Omicron-infected patients both with and without hypertension. Nonpharmaceutical intervention including dietary guidance and psychiatric therapy are crucial for BP control during the long COVID-19 period.

Identifiants

pubmed: 38195459
doi: 10.1186/s12889-023-17633-0
pii: 10.1186/s12889-023-17633-0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

134

Subventions

Organisme : National Natural Science Foundation of China
ID : 12171396
Organisme : National Natural Science Foundation of China
ID : 32171152

Informations de copyright

© 2024. The Author(s).

Références

Wolter N, Jassat W, Walaza S, Welch R, Moultrie H, Groome M, Amoako DG, Everatt J, Bhiman JN, Scheepers C, Tebeila N, Chiwandire N, du Plessis M, Govender N, Ismail A, Glass A, Mlisana K, Stevens W, Treurnicht FK, Makatini Z, Hsiao NY, Parboosing R, Wadula J, Hussey H, Davies MA, Boulle A. Von Gottberg A and Cohen C. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet. 2022;399:437–46.
pubmed: 35065011 pmcid: 8769664 doi: 10.1016/S0140-6736(22)00017-4
Maslo C, Friedland R, Toubkin M, Laubscher A, Akaloo T, Kama B. Characteristics and outcomes of hospitalized patients in South Africa during the COVID-19 Omicron Wave compared with previous waves. JAMA. 2022;327:583–4.
pubmed: 34967859 doi: 10.1001/jama.2021.24868
Cheung PH, Chan CP, Jin DY. Lessons learned from the fifth wave of COVID-19 in Hong Kong in early 2022. Emerg Microbes Infections. 2022;11:1072–8.
doi: 10.1080/22221751.2022.2060137
Li X, Zhong X, Wang Y, Zeng X, Luo T, Liu Q. Clinical determinants of the severity of COVID-19: a systematic review and meta-analysis. PLoS ONE. 2021;16:e0250602.
pubmed: 33939733 pmcid: 8092779 doi: 10.1371/journal.pone.0250602
Shu L, Wang X, Li M, Chen X, Ji N, Shi L, Wu M, Deng K, Wei J, Wang X, Cao Y, Yan J, Feng G. Clinical characteristics of moderate COVID-19 patients aggravation in Wuhan Stadium Cabin Hospital: a 571 cases of retrospective cohort study. J Med Virol. 2021;93:1133–40.
pubmed: 32779760 doi: 10.1002/jmv.26414
Zhang X, Zhang W, Chen S. Shanghai’s life-saving efforts against the current omicron wave of the COVID-19 pandemic. Lancet. 2022;399:2011–2.
pubmed: 35533708 pmcid: 9075855 doi: 10.1016/S0140-6736(22)00838-8
Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? The Lancet Respiratory Medicine. 2020;8:e21.
pubmed: 32171062 pmcid: 7118626 doi: 10.1016/S2213-2600(20)30116-8
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS, China Medical Treatment Expert Group for C. Clinical characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382:1708–20.
pubmed: 32109013 doi: 10.1056/NEJMoa2002032
Lippi G, Wong J, Henry BM. Hypertension in patients with coronavirus disease 2019 (COVID-19): a pooled analysis. Pol Archives Intern Med. 2020;130:304–9.
Sheppard JP, Nicholson BD, Lee J, McGagh D, Sherlock J, Koshiaris C, Oke J, Jones NR, Hinton W, Armitage L, Van Hecke O, Lay-Flurrie S, Bankhead CR, Liyanage H, Williams J, Ferreira F, Feher MD, Ashworth AJ, Joy MP, de Lusignan S, Hobbs FDR. Association between Blood Pressure Control and coronavirus disease 2019 outcomes in 45 418 symptomatic patients with hypertension: an Observational Cohort Study. Hypertension. 2021;77:846–55.
pubmed: 33325240 doi: 10.1161/HYPERTENSIONAHA.120.16472
Endo K, Miki T, Itoh T, Kubo H, Ito R, Ohno K, Hotta H, Kato N, Matsumoto T, Kitamura A, Tamayama M, Wataya T, Yamaya A, Ishikawa R, Ooiwa H. Impact of the COVID-19 pandemic on Glycemic Control and blood pressure control in patients with diabetes in Japan. Intern Med. 2022;61:37–48.
pubmed: 34980759 pmcid: 8810256 doi: 10.2169/internalmedicine.8041-21
Qiu J, Shen B, Zhao M, Wang Z, Xie B, Xu Y. A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations. Gen Psychiatry. 2020;33:e100213.
doi: 10.1136/gpsych-2020-100213
Dingess PM, Thakar A, Zhang Z, Flynn FW, Brown TE. High-salt exposure during Perinatal Development enhances stress sensitivity. Dev Neurobiol. 2018;78:1131–45.
pubmed: 30136369 pmcid: 6214711 doi: 10.1002/dneu.22635
Gilman TL, Mitchell NC, Daws LC, Toney GM. Neuroinflammation contributes to high salt intake-augmented neuronal activation and active coping responses to acute stress. Int J Neuropsychopharmacol. 2019;22:137–42.
pubmed: 30535261 doi: 10.1093/ijnp/pyy099
Laffin LJ, Kaufman HW, Chen Z, Niles JK, Arellano AR, Bare LA, Hazen SL. Rise in blood pressure observed among US adults during the COVID-19 pandemic. Circulation. 2022;145:235–7.
pubmed: 34865499 doi: 10.1161/CIRCULATIONAHA.121.057075
Yilmaz C, Gokmen V. Neuroactive compounds in foods: occurrence, mechanism and potential health effects. Food Res Int. 2020;128:108744.
pubmed: 31955786 doi: 10.1016/j.foodres.2019.108744
Rolland B, Haesebaert F, Zante E, Benyamina A, Haesebaert J, Franck N. Global Changes and Factors of Increase in Caloric/Salty Food Intake, screen use, and Substance Use during the early COVID-19 Containment Phase in the General Population in France: Survey Study. JMIR Public Health and Surveillance. 2020;6:e19630.
pubmed: 32589149 pmcid: 7505683 doi: 10.2196/19630
Zhang X, Chen B, Jia P, Han J. Locked on salt? Excessive consumption of high-sodium foods during COVID-19 presents an underappreciated public health risk: a review. Environ Chem Lett. 2021;19:3583–95.
pubmed: 34093102 pmcid: 8167309 doi: 10.1007/s10311-021-01257-0
Oliveira-Maia AJ, Roberts CD, Simon SA, Nicolelis MA. Gustatory and reward brain circuits in the control of food intake. Adv Tech Stand Neurosurg. 2011;36:31–59.
pubmed: 21197607 pmcid: 3434955 doi: 10.1007/978-3-7091-0179-7_3
Batis C, Gordon-Larsen P, Cole SR, Du S, Zhang B, Popkin B. Sodium intake from various time frames and incident hypertension among Chinese adults. Epidemiology. 2013;24:410–8.
pubmed: 23466527 pmcid: 3909658 doi: 10.1097/EDE.0b013e318289e047
He J, Huang JF, Li C, Chen J, Lu X, Chen JC, He H, Li JX, Cao J, Chen CS, Bazzano LA, Hu D, Kelly TN, Gu DF. Sodium Sensitivity, Sodium Resistance, and incidence of hypertension: a Longitudinal Follow-Up study of Dietary Sodium intervention. Hypertension. 2021;78:155–64.
pubmed: 33896191 doi: 10.1161/HYPERTENSIONAHA.120.16758
Li Q, Cui Y, Jin R, Lang H, Yu H, Sun F, He C, Ma T, Li Y, Zhou X, Liu D, Jia H, Chen X, Zhu Z. Enjoyment of Spicy Flavor enhances central salty-taste perception and reduces salt intake and blood pressure. Hypertension. 2017;70:1291–9.
pubmed: 29089370 doi: 10.1161/HYPERTENSIONAHA.117.09950
2018 Chinese guidelines for the management of hypertension. Chin J Cardiovasc Med. 2019.
Li Q, Li Q, Sun F, Yan G, Lang H, Zhu Z. Enhancement of Orbitofrontal and Insular cortices responses to Spicy Perception increases high Salt sensation: an event–related potentials study. Heart Mind. 2019; 3.
Dobkin RD, Mann SL, Gara MA, Interian A, Rodriguez KM, Menza M. Telephone-based cognitive behavioral therapy for depression in Parkinson disease: a randomized controlled trial. Neurology. 2020;94:e1764–73.
pubmed: 32238507 pmcid: 7282876 doi: 10.1212/WNL.0000000000009292
Turner AI, Smyth N, Hall SJ, Torres SJ, Hussein M, Jayasinghe SU, Ball K, Clow AJ. Psychological stress reactivity and future health and disease outcomes: a systematic review of prospective evidence. Psychoneuroendocrinology. 2020;114:104599.
pubmed: 32045797 doi: 10.1016/j.psyneuen.2020.104599
Chrousos GP. Stress and disorders of the stress system. Nat Reviews Endocrinol. 2009;5:374–81.
doi: 10.1038/nrendo.2009.106
Murakami N, Hayden R, Hills T, Al-Samkari H, Casey J, Del Sorbo L, Lawler PR, Sise ME, Leaf DE. Therapeutic advances in COVID-19. Nat Rev Nephrol. 2023;19(1):38–52.
pubmed: 36253508 doi: 10.1038/s41581-022-00642-4
Amraei R, Rahimi N. COVID-19, renin-angiotensin system and endothelial dysfunction. Cells. 2020;9(7):1652.
pubmed: 32660065 pmcid: 7407648 doi: 10.3390/cells9071652
He FJ, Tan M, Ma Y, MacGregor GA. Salt reduction to prevent hypertension and Cardiovascular Disease: JACC State-of-the-art review. J Am Coll Cardiol. 2020;75:632–47.
pubmed: 32057379 doi: 10.1016/j.jacc.2019.11.055
Garfinkle MA. Salt and essential hypertension: pathophysiology and implications for treatment. J Am Soc Hypertension: JASH. 2017;11:385–91.
pubmed: 28479261 doi: 10.1016/j.jash.2017.04.006
Mutchler SM, Kirabo A, Kleyman TR. Epithelial Sodium Channel and Salt-Sensitive Hypertension. Hypertension. 2021;77(3):759–67.
pubmed: 33486988 doi: 10.1161/HYPERTENSIONAHA.120.14481
Pearce L, Davidson SM, Yellon DM. The cytokine storm of COVID-19: a spotlight on prevention and protection. Expert Opin Ther Targets. 2020;24(8):723–30.
pubmed: 32594778 doi: 10.1080/14728222.2020.1783243
Cárdenas-Rodríguez N, Bandala C, Vanoye-Carlo A, Ignacio-Mejía I, Gómez-Manzo S, Hernández-Cruz EY, Pedraza-Chaverri J, Carmona-Aparicio L, Hernández-Ochoa B. Use of antioxidants for the Neuro-Therapeutic Management of COVID-19. Antioxid (Basel). 2021;10(6):971.
doi: 10.3390/antiox10060971
Fodor A, Tiperciuc B, Login C, Orasan OH, Lazar AL, Buchman C, Hanghicel P, Sitar-Taut A, Suharoschi R, Vulturar R, Cozma A. Endothelial dysfunction, inflammation, and oxidative stress in COVID-19-Mechanisms and therapeutic targets. Oxid Med Cell Longev. 2021;2021:8671713.
pubmed: 34457119 pmcid: 8397545 doi: 10.1155/2021/8671713
Zhang X, Chen B, Jia P, Han J. Locked on salt? Excessive consumption of high-sodium foods during COVID-19 presents an underappreciated public health risk: a review. Environ Chem Lett. 2021;19(5):3583–95.
pubmed: 34093102 pmcid: 8167309 doi: 10.1007/s10311-021-01257-0
Russo SJ, Nestler EJ. The brain reward circuitry in mood disorders. Nat Rev Neurosci. 2013;14:609–25.
pubmed: 23942470 doi: 10.1038/nrn3381
Mitchell NC, Gilman TL, Daws LC, Toney GM. High salt intake enhances swim stress-induced PVN vasopressin cell activation and active stress coping. Psychoneuroendocrinology. 2018;93:29–38.
pubmed: 29684712 pmcid: 6269109 doi: 10.1016/j.psyneuen.2018.04.003
Kobayashi K, Chin K, Umezawa S, Ito S, Yamamoto H, Nakano S, Takada N, Hatori N, Tamura K. Influence of stress induced by the first announced state of emergency due to coronavirus disease 2019 on outpatient blood pressure management in Japan. Hypertens Research: Official J Japanese Soc Hypertens. 2022;45:675–85.
doi: 10.1038/s41440-021-00832-w
Ito S, Kobayashi K, Chin K, Umezawa S, Yamamoto H, Nakano S, Takada N, Hatori N, Tamura K. Impact of the first announced state of emergency owing to coronavirus disease 2019 on stress and blood pressure levels among patients with type 2 diabetes mellitus in Japan. J Diabetes Invest. 2022;13:1607–16.
doi: 10.1111/jdi.13813
Hackett RA, Steptoe A. Type 2 diabetes mellitus and psychological stress - a modifiable risk factor. Nat Reviews Endocrinol. 2017;13:547–60.
doi: 10.1038/nrendo.2017.64
Ali S, Stone MA, Peters JL, Davies MJ, Khunti K. The prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysis. Diabet Medicine: J Br Diabet Association. 2006;23:1165–73.
doi: 10.1111/j.1464-5491.2006.01943.x
Smith KJ, Beland M, Clyde M, Gariepy G, Page V, Badawi G, Rabasa-Lhoret R. And Schmitz N. Association of diabetes with anxiety: a systematic review and meta-analysis. J Psychosom Res. 2013;74:89–99.
pubmed: 23332522 doi: 10.1016/j.jpsychores.2012.11.013
Saito K, Kim JI, Maekawa K, Ikeda Y, Yokoyama M. The great Hanshin-Awaji earthquake aggravates blood pressure control in treated hypertensive patients. Am J Hypertens. 1997;10:217–21.
pubmed: 9037331 doi: 10.1016/S0895-7061(96)00351-2
Celik M, Yilmaz Y, Karagoz A, Kahyaoglu M, Cakmak EO, Kup A, Celik FB, Karaduman A, Kulahcioglu S, Izci S, Gecmen C, Caliskan M. Anxiety disorder Associated with the COVID-19 pandemic causes deterioration of blood pressure control in primary hypertensive patients. Medeniyet Med J. 2021;36:83–90.
Pengo MF, Albini F, Guglielmi G, Mollica C, Soranna D, Zambra G, Zambon A, Bilo G, Parati G. Home blood pressure during COVID-19-related lockdown in patients with hypertension. Eur J Prev Cardiol. 2022;29:e94–6.
pubmed: 33899916 doi: 10.1093/eurjpc/zwab010
Feitosa F, Feitosa ADM, Paiva AMG, Mota-Gomes MA, Barroso WS, Miranda RD, Barbosa ECD, Brandao AA, Lima-Filho JL, Sposito AC, Coca A, Nadruz W Jr. Impact of the COVID-19 pandemic on blood pressure control: a nationwide home blood pressure monitoring study. Hypertens Research: Official J Japanese Soc Hypertens. 2022;45:364–8.
doi: 10.1038/s41440-021-00784-1
Han J, Zhang X, He S, Jia P. Can the coronavirus disease be transmitted from food? A review of evidence, risks, policies and knowledge gaps. Environ Chem Lett. 2021;19:5–16.
pubmed: 33024427 doi: 10.1007/s10311-020-01101-x
Abdul Rahman H, Julaini NN, Zaim SNN, Masri NA, Abdul-Mumin KH. Mental Wellbeing and Health-Risk behaviours of University students in Brunei: a cross-sectional study during COVID-19 pandemic. Healthc (Basel). 2023;11(16):2327.
Rahman HA, Amornsriwatanakul A, Abdul-Mumin KH, Agustiningsih D, Chaiyasong S, Chia M, Chupradit S, Huy LQ, Ivanovitch K, Nurmala I, Majid HBA, Nazan AINM, Rodjarkpai Y, de la Cruz MHTO, Mahmudiono T, Sriboonma K, Sudnongbua S, Vidiawati D, Wattanapisit A, Charoenwattana S, Cahyani N, Car J, Ho MR, Rosenberg M. Prevalence of Health-Risk behaviors and Mental Well-Being of ASEAN University students in COVID-19 pandemic. Int J Environ Res Public Health. 2022;19(14):8528.
pubmed: 35886375 pmcid: 9320216 doi: 10.3390/ijerph19148528
Singh SA, Dhanasekaran D, Ganamurali N, Sabarathinam LP. Junk food-induced obesity- a growing threat to youngsters during the pandemic. Obes Med. 2021;26:100364.
doi: 10.1016/j.obmed.2021.100364
Chinese Preventive Medicine Association. Chinese guideline on healthy lifestyle to prevent cardiometabolic diseases. Chin J Prev Med. 2020;54(3):256–77.
Chinese Society of Cardiology. Chinese experts consensus on diagnosis and management of salt-sensitive hypertension. Chin J Cardiol. 2023;51(4):364–76.
Vaillant MF, Alligier M, Baclet N, Capelle J, Dousseaux MP, Eyraud E, Fayemendy P, Flori N, Guex E, Hennequin V, Lavandier F, Martineau C, Morin MC, Mokaddem F, Parmentier I, Rossi-Pacini F, Soriano G, Verdier E, Zeanandin G, Quilliot D. Guidelines on standard and therapeutic diets for adults in hospitals by the French Association of Nutritionist Dieticians (AFDN) and the French Speaking Society of Clinical Nutrition and Metabolism (SFNCM). Nutrients. 2021;13(7):2434.
pubmed: 34371943 pmcid: 8308628 doi: 10.3390/nu13072434

Auteurs

Chenyi Wang (C)

Department of Urology Surgery, Daping Hospital, Army Medical University, 400042, Chongqing, China.

Wanhong Tan (W)

Chongqing Yuzhong District Daping Street Community Health Service Center, 400042, Chongqing, PR China.

Xiaoxiao Liu (X)

Center for Hypertension and Metabolic Diseases, Department of Hypertension and Endocrinology, Daping Hospital, Chongqing Institute of Hypertension, Army Medical University, 400042, Chongqing, PR China.
Department of Nephrology, Beijing Key Laboratory of Kidney Disease Research, First Medical Center of Chinese PLA General Hospital, 100853, Beijing, China.

Miao He (M)

Center for Hypertension and Metabolic Diseases, Department of Hypertension and Endocrinology, Daping Hospital, Chongqing Institute of Hypertension, Army Medical University, 400042, Chongqing, PR China.

Shi Zeng (S)

Department of Neurosurgery, People's Hospital of Chongqing Banan District, 401320, Chongqing, PR China.

Maojie Sun (M)

Department of Pharmacy, The Seventh People's Hospital of Chongqing, 400054, Chongqing, PR China.

Lijuan Yan (L)

Department of Urology Surgery, Daping Hospital, Army Medical University, 400042, Chongqing, China.

Min Li (M)

Department of Urology Surgery, Daping Hospital, Army Medical University, 400042, Chongqing, China.

Kun Zhan (K)

Department of Urology Surgery, Daping Hospital, Army Medical University, 400042, Chongqing, China.

Kaifa Wang (K)

School of Mathematics and Statistics, Southwest University, 400715, Chongqing, PR China. kfwang72@163.com.

Qiang Li (Q)

Center for Hypertension and Metabolic Diseases, Department of Hypertension and Endocrinology, Daping Hospital, Chongqing Institute of Hypertension, Army Medical University, 400042, Chongqing, PR China. liqianglife@126.com.

Classifications MeSH